Tech Backlash Meets Breakthrough: A Cancer Vaccine Offers Hope
The Washington Post’s Editorial Board argues that the Moderna-Merck cancer vaccine—a breakthrough driven by advances in genomics and computing—shows how cutting-edge medical tech can overcome resistance to new science, offering life-saving hope to the 100,000+ Americans affected by skin cancer annually and the more than 8,000 who die each year.